AJRR Participants Can Now Submit Level II Patient Risk Factor Data
The American Joint Replacement Registry (AJRR), the registry for the collection of hip and knee replacement data, has released new data specifications that allow for healthcare institutions to collect and report on Level II patient risk factors, comorbidities, and complications data.
The addition of Level II completes the AJRR dataset, and gives registry participants risk adjusted data they can use to determine survivorship curves.
“The ability to analyze patient risk factors is essential to the AJRR’s mission to improve orthopaedic care,” said Daniel J. Berry, MD, chairman of the AJRR board of directors.
“Level II data introduces many variables that health care providers may consider when planning for surgery. Surgeons will be able to utilize this new data to better inform their decisions, and our ability to risk adjust will allow for their findings to not be misconstrued.”
The new specifications also include expanded Level I procedural data elements and modified Level III patient-reported outcomes data elements that provide a template for the Centers for Medicare & Medicaid Services’ Comprehensive Care for Joint Replacement (CJR) model. AJRR is now able to help with both the patient-reported outcome and risk assessment elements of CJR.
“As orthopaedics continues to stress the importance of quality, the AJRR continues to evolve to meet our participants’ needs,” Dr. Berry said. “Initiatives and bundled payments are one of many factors that influence the actions that health care providers engage in.
“Our registry platform provides an avenue for surgeons and other hospital staff to meet these programs’ requirements while also giving a deeper, more exact view of patient outcomes.”
The AJRR currently has nearly 1,000 participating institutions and more than 6,300 participating surgeons. It recently reached the milestone of collecting data on its one millionth hip and knee procedure.
More information on the AJRR’s new data specifications is available here.